混合糖电解质注射液辅助治疗晚期非小细胞肺癌的疗效及对免疫的影响 Clinical efficacy and immunomodulatory effect of carbohydrate and electrolyte injection on advanced non-small cell lung cancer patients
Wang H,Naghavi M,Allen C,et al.Global,regional,and national life expectancy,all-cause mortality,and cause-specific mortality for 249 causes of death,1980-2015:a systematic analysis for the Global Burden of Disease Study 2015[J].Lancet,2016,388(10 053):1 459-1 544.
[2]
Miyai T,Hojyo S,Ikawa T,et al.Zinc transporter SLC39A10/ZIP10 facilitates antiapoptotic signaling during early B-cell development[J].Proc Natl Acad Sci USA,2014,111(32):11 780-11 785.
Bezjak A,Temin S,Franklin G,et al.Definitive and adjuvant radiotherapy in locally advanced non-small-cell lung cancer:American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline[J].J Clin Oncol,2015,33(18):2 100-2 105.
Siegel RL,Miller KD,Jemal A.Cancer statistics,2017[J].CA Cancer J Clin,2017,67(1):7-30.
[8]
Fang Z,Chen W,Yuan Z,et al.LncRNA-MALAT1contributes to the cisplatin-resistance of lung cancer by upregulating MRP1 and MDR1 via STAT3 activation[J].Biomed Pharmacother,2018,101(3):536-542.
[9]
Priebatsch KM,Kvansakul M,Poon IK,et al.Functional regulation of the plasma protein histidine-rich glycoprotein by Zn2+in settings of tissue injury[J].Biomolecules,2017,7(1):pii:E22.
[10]
Himmelstein DS,Cajigas I,Bi C,et al.SHH E176/E177-Zn2+conformation is required for signaling at endogenous sites[J].Dev Biol,2017,424(2):221-235.
[11]
Knocke S,Fleischmann-Mundt B,Saborowski M,et al.Tailored tumor immunogenicity reveals regulation of CD4 and CD8 T cell responses against cancer[J].Cell Rep,2016,17(9):2 234-2 246.
[12]
Novello S,Mazières J,Oh IJ,et al.Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase(ALK)-positive non-small-cell lung cancer:results from the phaseⅢALUR study[J].Ann Oncol,2018,29(6):1 409-1 416.
[13]
Chen S,Cheng YL,Li ST,et al.Effect analysis of chemoradiotherapy after operation in patients with stageⅢA non-small cell lung cancer[J].Asian Pac J Trop Med,2012,5(10):823-827.
[14]
Curran WJ,Paulus R,Langer CJ,et al.Sequential vs.concurrent chemoradiation for stageⅢnon-small cell lung cancer:randomized phaseⅢtrial RTOG 9410[J].J Natl Cancer Inst,2011,103(19):1 452-1 460.
[15]
Borghaei H,Paz-Ares L,Horn L,et al.Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer[J].N Engl J Med,2015,373(17):1 627-1 639.
